Clinical Trials Logo

Pain, Acute clinical trials

View clinical trials related to Pain, Acute.

Filter by:

NCT ID: NCT04388111 Completed - Pain, Acute Clinical Trials

Intraosseous Morphine in Primary TKA

Start date: May 5, 2020
Phase: Phase 4
Study type: Interventional

The research team wants to investigate if an intraosseous injection (directly into the bone marrow) of morphine during primary total knee replacement helps with post-operative pain following primary total knee replacement surgery. For this study patients will either be randomized into one of two groups: Group 1: Receives an intraosseous injection of morphine (mixed with standard antibiotics) during their primary total knee replacement or Group 2: Serves as the control group and only receives an intraosseous injection of antibioitics during their total knee replacement. The research team will have patients fill out a symptom journal for two weeks following their surgery to measure pain levels and pain medication consumed throughout the day as well as nausea and other symptoms. Additionally, the research team will take blood samples both intraoperatively and post-operatively (10 hours post-op) to measure the level of inflammatory markers as well as morphine.

NCT ID: NCT04387136 Completed - Pain Clinical Trials

Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center

Start date: October 14, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time.

NCT ID: NCT04356963 Completed - Clinical trials for Traumatic Brain Injury

Adjunct VR Pain Management in Acute Brain Injury

Start date: September 5, 2020
Phase: N/A
Study type: Interventional

Severe and refractory pain after acute injury is a known-risk factor for chronic opioid use disorder. In this study, the investigators will use Virtual Reality (VR) immersion as a non-pharmacological adjunct to treat pain associated with acute traumatic injuries, including traumatic brain injury. The investigators hypothesize that VR therapy will decrease pain and reduce opioid use in patients with acute traumatic injuries, including TBI.

NCT ID: NCT04356820 Completed - Pain, Acute Clinical Trials

The Effect of Music Played and Acupressure Application on Pain and Anxiety in Women Undergoing Gynecological Examination

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This study was carried out to determine the effect of listening to music and acupressure application in reducing pain and anxiety during gynecological examination.

NCT ID: NCT04287803 Completed - Trauma Clinical Trials

Prehospital Analgesia in Adults Using Inhaled Methoxyflurane : A Feasibility Study

Start date: April 12, 2021
Phase: Phase 4
Study type: Interventional

Pain is common and can contribute to both psychological and physiological effects if not treated. Currently primary care paramedics have limited selections within their pain management tool box. This contributes to inadequate pain management. Methoxyflurane is a safe, easy and effective choice in prehospital management of pain. The impact of this feasibility trial, will hope to inform the larger multi-centred trial and then support the implementation of out-of-hospital Canadian National Guidelines for prehospital pain control, enabling paramedics to provide rapid, effective prehospital pain relief to patients.

NCT ID: NCT04281836 Completed - Pain, Acute Clinical Trials

Visual and Auditory Neuromodulation of Pain Perception

Start date: February 11, 2016
Phase: N/A
Study type: Interventional

Medical and dental patients may experience fear commonly attributed to physical pain during the visit. By reducing pain perception, patient comfort and future patient compliance may be improved. Patient health may be improved by increasing compliance and promoting increased visits. This can lead to more frequent and timely preventative actions. The research purpose is to establish quantitative and qualitative data to support current, non-pharmacological methods for reducing pain sensitivity. More specifically, the investigators aim to determine if the use of auditory and visual (3D imaging) stimuli related to the regulation of breathing can decrease or modulate pain. Healthy participants between the ages of 18 and 60 will participate in a one week study, with two in lab appointments on day one and day seven. Participants will be split into two groups, one will undergo breathing awareness using auditory and visual technology (i.e. listen to one's own breathing with headphones and watch 3D image of lungs using virtual headset), and the second group will have breathing awareness without the use of technology (i.e. simply focusing on one's own breathing). At each appointment, the investigators will collect pain threshold data using thermal Quantitative Sensory Testing (tQST) and brain activity data using Functional near-infrared spectroscopy (fNIRS). tQST and fNIRS data will be collected before, during, and after each breathing awareness/control exercise. Quantifying change in pain intensity has been demonstrated by pain threshold comparison across a stimulus using thermal Quantitative Sensory Testing (tQST). Functional near-infrared spectroscopy (fNIRS) in coordination with pain stimulation has been shown effective at locating different hemodynamic cortical responses depending on pain perception and expectation. In the current study, functional resting states before and after pain stimulation will be quantitatively assessed using fNIRS. The study design will allow the investigators to determine if the use of auditory and visual (3D imaging) stimuli related to the regulation of breathing can decrease or modulate pain. Cortical responses will give additional insight into the areas related to the decreased pain threshold. The long term objective is to increase neurophysiological understanding that will improve patient care. If effective, the novel experimental methods used will help to standardize future pain evaluation techniques.

NCT ID: NCT04280796 Completed - Low Back Pain Clinical Trials

Changes in Affective Pain Processing in Human Volunteers

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The experience of pain is more than the conscious perception of nociceptive signals. Emotional and motivational aspects accompany pain, leading to its aversiveness and motivation for avoidance. In chronic pain, a negative hedonic shift has been proposed that is characterized by disproportionally increased emotional-motivational compared to sensory-discriminative pain responses. Such a negative hedonic shift is, for example, mirrored in very high comorbidity rates of chronic pain and affective disorders such as depression and anxiety. The aim of this study is to develop methods that allow the differentiation of sensory-discriminative and emotional-motivational pain response and to characterize mechanisms of the negative hedonic shift.

NCT ID: NCT04271917 Completed - Pain, Acute Clinical Trials

Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients

SWAP
Start date: February 24, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.

NCT ID: NCT04252833 Completed - Surgery Clinical Trials

Open-label, Crossover, Food Effect Study to Evaluate CT-044 in Healthy Human Volunteers

Start date: February 18, 2020
Phase: Phase 1
Study type: Interventional

This open-label study will be conducted to assess the bioavailability and PK of oral single doses of CT-044 following administration with and without food and to evaluate the safety and tolerability of CT-044 when given with and without food.

NCT ID: NCT04245475 Completed - Pain, Acute Clinical Trials

Water-friendly Virtual Reality and Brief Thermal Pain

Start date: January 30, 2020
Phase: N/A
Study type: Interventional

Using immersive virtual reality as a form of pain distraction during a brief "painful but tolerable" temperature.